Comparative pharmacokinetic analysis of sporoderm‐broken and sporoderm‐removed Ganoderma lucidum spore in rat by using a sensitive plasma UPLC–QqQ–MS method
Biomedical Chromatography · 2024-02 · 38 (2)
DOI: 10.1002/bmc.5787 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomedical Chromatography, 2023-12. Verfasst von Dongjie Chen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Hangzhou Yuhang Boyu Intelligent Health Innovation Laboratory, Hangzhou, China. Hauptthemen laut MEDLINE: Reishi, Triterpenes. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 30 Literaturangaben. Gefördert von: Zhejiang Key Agricultural Enterprise Institute of China, Zhejiang Science and Technology Major Program on Agricultural New Variety Breeding of China.
Abstract (Originalsprache)
Previous studies have found that removing the sporoderm significantly enhanced antitumor and immunoregulatory activities of Ganoderma lucidum spore (GLS) compared with breaking the sporoderm. However, the pharmacokinetics of sporoderm‐removed GLS (RGLS) and sporoderm‐broken GLS (BGLS) remain elusive. To compare the pharmacokinetic differences between the two products, we developed a UPLC–QqQ MS method for determining nine representative triterpenoid concentrations. Chloramphenicol was used as an internal standard. The samples were separated on a reversed‐phase column using acetonitrile–0.1% formic acid and water–0.1% formic acid as mobile phases. Nine triterpenoids were analyzed using multiple reaction monitoring mode. The results showed that the area under the concentration–time curve from dosing to time t of all nine components was increased in RGLS compared with BGLS. And the time to the maximum concentration in BGLS was delayed compared with that of RGLS. These indicated that the absorption of RGLS was better than that of BGLS, and the sporoderm might hinder the absorption of the active components. These results increase our understanding of the bioavailability of BGLS and RGLS and indicate that increased bioavailability is one of the main reasons for the enhanced efficacy of RGLS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Hangzhou Yuhang Boyu Intelligent Health Innovation Laboratory, Hangzhou, China.
- Jiangsu Collaborative Innovation Center of Chinese Medicinal Resources Industrialization, National and Local Collaborative Engineering Center of Chinese Medicinal Resources Industrialization and Formulae Innovative Medi…
- Zhejiang Engineering Research Center of Rare Medicinal Plants, Wuyi, China.
- School of Pharmaceutical Engineering, Shenyang Pharmaceutical University, Shenyang, China.
ORCID-Profile: Dongjie Chen, Jihong Yang
Förderung
- Zhejiang Key Agricultural Enterprise Institute of China
- Zhejiang Science and Technology Major Program on Agricultural New Variety Breeding of China
Zitieren
APA
Chen, D., Zhang, G., Yang, J., Yu, H., Xue, J., Zhang, L., & Li, Z. (2024). Comparative pharmacokinetic analysis of sporoderm‐broken and sporoderm‐removed Ganoderma lucidum spore in rat by using a sensitive plasma UPLC–QqQ–MS method. Biomedical Chromatography, 38(2). https://doi.org/10.1002/bmc.5787
Vancouver
Chen D, Zhang G, Yang J, Yu H, Xue J, Zhang L, et al. Comparative pharmacokinetic analysis of sporoderm‐broken and sporoderm‐removed Ganoderma lucidum spore in rat by using a sensitive plasma UPLC–QqQ–MS method. Biomedical Chromatography. 2024;38(2). doi:10.1002/bmc.5787
BibTeX
@article{Chen2024,
author = {Chen, Dongjie and Zhang, Guoliang and Yang, Jihong and Yu, Huanhuan and Xue, Jin and Zhang, Lu and Li, Zhenhao},
title = {Comparative pharmacokinetic analysis of sporoderm‐broken and sporoderm‐removed Ganoderma lucidum spore in rat by using a sensitive plasma UPLC–QqQ–MS method},
journal = {Biomedical Chromatography},
year = {2024},
volume = {38},
number = {2},
doi = {10.1002/bmc.5787}
}
EUVIMED